TNF and Alzheimer disease: As shown in Figure 9a, the expression level of TNF-α in the AD group was significantly higher (22.9-fold) than the CON group; however, this elevation was significantly reduced by treatment with AD+CA-80 and AD+CA-200 (2.7- and 1.6-fold, respectively).